Optimi Health granted Natural Health Product Site Licence by Health Canada
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-Methylenedioxymethamphetamine (MDMA), natural GMP-grade psilocybin, along with natural health product formulations, is pleased to announce the receipt of its Natural Health Product Site Licence following an assessment by...
Read More
